Matica Enterprises' subsidiary, RoyalMax Biotechnology Canada, has entered into a Purchase Agreement with Rangers Pharmaceuticals ("Rangers"), to acquire cannabis genetics from the first legally registered seed bank in Europe.
"Under the Purchase Agreement, RoyalMax will acquire high THC varieties such as Wakeford, Pineapple Express, and Triumphant that are expected to be well received by the Canadian market," the team with the company explains. "Franchise's collection of genetics consists of over 220 strains, bred by award world-renowned breeder Charles Scott. Mr. Scott has won numerous globally recognized awards including an induction into the High Times Hall of Fame and 19 Cannabis Cups for THC strains such as Love Potion #1, Willie Nelson, and Pink Kush."
"RoyalMax will introduce new cannabis varieties unique to the Canadian market. Currently there is a lack of genetic diversity within the Canadian market. RoyalMax will have the ability to offer new and unique product varieties to our consumers. Through this relationship, RoyalMax will benefit from one of the most complete and sought-after genetics collections in the world," said Boris Ziger, the CEO of Matica.
"Matica will have a distinct advantage within the Canadian market by utilizing some of our top strains, such as the highly unique and potent Triumphant, which have not yet been introduced to the Canadian market. Franchise is excited to fill this gap and work with innovators in the industry, such as Matica to effectively cultivate and distribute product based on our unique cultivars," commented Clifford Starke, the CEO of Franchise Cannabis Corp.
For more information:
Matica Enterprises
maticaenterprises.com